Document:

<PAGE>   1

                                                                     EXHIBIT 4.4

                                                                        ANNEX VI
                                                                              TO
                                                   SECURITIES PURCHASE AGREEMENT

                                FORM OF WARRANT

THESE SECURITIES AND THE SECURITIES ISSUABLE UPON THEIR EXERCISE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933 AND MAY NOT BE TRANSFERRED UNLESS
COVERED BY AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT, A "NO ACTION"
LETTER FROM THE SECURITIES AND EXCHANGE COMMISSION WITH RESPECT TO SUCH
TRANSFER, A TRANSFER MEETING THE REQUIREMENTS OF RULE 144 OF THE SECURITIES AND
EXCHANGE COMMISSION, OR AN OPINION OF COUNSEL SATISFACTORY TO THE ISSUER TO THE
EFFECT THAT ANY SUCH TRANSFER IS EXEMPT FROM SUCH REGISTRATION.

                                   SATX, INC.

                         COMMON STOCK PURCHASE WARRANT

         1.  ISSUANCE.  In consideration of good and valuable consideration, the
receipt of which is hereby acknowledged by SATX, INC., a Nevada corporation (the
"Company"), ____________ , or registered assigns (the "Holder") is hereby
granted the right to purchase at any time commencing and continuing until
5:00 P.M., New York City time, on __________________ , 200___(1) (the
"Expiration Date"), _________ Thousand (____)(2) fully paid and nonassessable
shares of the Company's Common Stock, par value $.001 per share (the "Common
Stock") at an initial exercise price of $______(3) per share (the "Exercise
Price"), subject to further adjustment as set forth herein.

---------------------

         (1) Insert date which is last day of month in which fifth anniversary
of the relevant Closing Date occurs.

         (2) Insert 100,000 for every $250,000 of Debenture purchased.

         (3) Insert amount equal to 120% of (y) Weighted Average Conversion
Price (as defined below).

"W.A.C.P." means (i) the sum of the Conversion Principal (as defined below) for
all conversions of the Debenture prior to such exercise, divided by (ii) the
aggregate principal of the Debenture converted prior to such exercise.

"Conversion Principal" means, for each conversion, (x) the principal amount of
the Debenture converted by such conversion, multiplied by (y) the Conversion
Price applicable to that conversion.

<PAGE>   2

         2.  Exercise of Warrants. This Warrant is exercisable in whole or in
part at the Exercise Price per share of Common Stock payable hereunder, payable
in cash or by certified or official bank check, or by means of tendering this
Warrant Certificate to the Company to receive a number of shares of Common Stock
equal in Market Value to the difference between the aggregate Market Value of
the shares of Common Stock issuable upon exercise of this Warrant and the total
cash exercise price thereof divided by the Market Volume. Upon surrender of this
Warrant Certificate with the annexed Notice of Exercise Form duly executed,
together with payment of the Exercise Price for the shares of Common Stock
purchased, the Holder shall be entitled to receive a certificate or certificates
for the shares of Common Stock so purchased.

         3.  Reservation of Shares. The Company hereby agrees that at all times
during the term of this Warrant there shall be reserved for issuance upon
exercise of this Warrant such number of shares of its Common Stock as shall be
required for issuance upon exercise of this Warrant (the "Warrant Shares").

         4.  Mutilation or Loss of Warrant. Upon receipt by the Company of
evidence satisfactory to it of the loss, theft, destruction or mutilation of
this Warrant, and (in the case of loss, theft or destruction) receipt of
reasonably satisfactory indemnification, and (in the case of mutilation) upon
surrender and cancellation of this Warrant, the Company will execute and deliver
a new Warrant of like tenor and date and any such lost, stolen, destroyed or
mutilated Warrant shall thereupon become void.

         5.  Rights of the Holder. The Holder shall not, by virtue hereof, be
entitled to any rights of a stockholder in the Company, either at law or equity,
and the rights of the Holder are limited to those expressed in this Warrant and
are not enforceable against the Company except to the extent set forth herein.

         6.  Protection Against Dilution.

             6.1  Adjustment Mechanism. If an adjustment of the Exercise Price
is required pursuant to this Section 6, the Holder shall be entitled to purchase
such number of additional shares of Common Stock as will cause (i) the total
number of shares of Common Stock Holder is entitled to purchase pursuant to this
Warrant, multiplied by (ii) the adjusted purchase price per share, to equal
(iii) the total number of shares of Common Stock Holder is entitled to purchase
before adjustment multiplied by the total purchase price before adjustment.

             6.2  Capital Adjustments. In case of any stock split or reverse
stock split, stock dividend, reclassification of the Common Stock,
recapitalization, merger or consolidation, or like capital adjustment affecting
the Common Stock of the Company, the provisions of this Section 6 shall be
applied as if such capital adjustment event had occurred immediately prior to
the date of this Warrant and the original purchase price had been fairly
allocated to the stock resulting from such capital adjustment; and in other
respects the provisions of this Section shall be applied in a fair, equitable
and reasonable manner so as to give effect, as nearly as may be, to the
purposes hereof.

                                       2

<PAGE>   3

A rights offering to stockholders shall be deemed a stock dividend to the
extent of the bargain purchase element of the rights.

         6.3      Adjustment for Spin Off.  If, for any reason, prior to the
exercise of this Warrant in full, the Company spins off or otherwise divests
itself of a part of its business or operations or disposes all or of a part of
its assets in a transaction (the "Spin Off") in which the Company does not
receive compensation for such business, operations or assets, but causes
securities of another entity (the "Spin Off Securities") to be issued to
security holders of the Company, then

         (a) the Company shall cause (i) to be reserved Spin Off Securities
equal to the number thereof which would have been issued to the Holder had all
of the Holder's unexercised Warrants outstanding on the record date (the "Record
Date") for determining the amount and number of Spin Off Securities to be issued
to security holders of the Company (the "Outstanding Warrants") been exercised
as of the close of business on the trading day immediately before the Record
Date (the "Reserved Spin Off Shares"), and (ii) to be issued to the Holder on
the exercise of all or any of the Outstanding Warrants, such amount of the
Reserved Spin Off Shares equal to (x) the Reserved Spin Off Shares multiplied by
(y) a fraction, of which (I) the numerator is the amount of the Outstanding
Warrants then being exercised, and (II) the denominator is the amount of the
Outstanding Warrants; and

         (b) the Exercise Price on the Outstanding Warrants shall be adjusted
immediately after consummation of the Spin Off by multiplying the Exercise Price
by a fraction (if, but only if, such fraction is less than 1.0), the numerator
of which is the Average Market Price of the Common Stock (as defined below) for
the five (5) trading days immediately following the fifth trading day after the
Record Day, and the denominator of which is the Average Market Price of the
Common Stock on the five (5) trading days immediately preceding the Record Date;
and such adjusted Exercise Price shall be deemed to be the Exercise Price with
respect to the Outstanding Warrants after the Record Date. As used herein, the
term "Average Market Price of the Common Stock" means the average closing bid
price of a share of Common Stock, as reported by Bloomberg, LP or, if not so
reported, as reported on the over-the-counter market for the relevant period.

         7.       Transfer to Comply with the Securities Act: Registration
Rights.

         (a) This Warrant has not been registered under the Securities Act of
1933, as amended, (the "Act") and has been issued to the Holder for investment
and not with a view to the distribution of either the Warrant or the Warrant
Shares. Neither this Warrant nor any of the Warrant Shares or any other security
issued or issuable upon exercise of this Warrant may be sold, transferred,
pledged or hypothecated in the absence of an effective registration statement
under the Act relating to such security or an opinion of counsel satisfactory to
the Company that registration is not required under the Act. Each certificate
for the Warrant, the Warrant Shares and any other security issued or issuable
upon exercise of this Warrant shall contain a legend on the face thereof,

                                       3
<PAGE>   4
in form and substance satisfactory to counsel for the Company, setting forth the
restrictions on transfer contained in this Section.

         (b)      The Company agrees to file a registration statement, which
shall include the Warrant Shares, in the "Registration Statement", as
contemplated by and pursuant to the Registration Rights Agreement between the
Company and Holder, dated September 13, 2000.

         8.       Notices. Any notice or other communication required or
permitted hereunder shall be in writing and shall be delivered personally,
telegraphed, telexed, sent by facsimile transmission or sent by certified,
registered or express mail, postage pre-paid. Any such notice shall be deemed
given when so delivered personally, telegraphed, telexed or sent by facsimile
transmission, or, if mailed, two days after the date of deposit in the United
States mails, as follows:

                  (i)      if the Company, to:

                           SATX, Inc.
                           4710 Eisenhower Blvd.
                           Suite B-2, Tampa
                           Florida 33634
                           Attention: Merritt Jesson-President
                           Tel No.: (800) 989-7289
                           Fax No.: (813) 290-0616

                           with a copy to:

                           Frohling, Hudak & Pellegrino, LLC
                           425 Eagle Rock Avenue
                           Roseland, New Jersey 07068
                           Attention: John B. M. Frohling, Esq.
                           Tel No.: (973) 226-4600
                           Fax No.: (973) 226-0969

                  (ii)     if to the Holder, to:

                           with a copy to:

                           Krieger & Prager LLP
                           Suite 1440
                           39 Broadway
                           New York, New York 10006
                           Tel No.: (212) 363-2900
                           Fax No.: (212) 363-2999

                                       4
<PAGE>   5

Any party may designate another address or person for receipt of notices
hereunder by notice given to the other parties in accordance with this Section.

         9.       If the Company fails to deliver to the Holder certificate or
certificates representing the Warrant Shares by the fifth (5th) trading day
after the date of exercise if the address for delivery is in the United States
(and by the seventh (7th) trading day after the date of exercise if the address
for the delivery is outside the United States) the Company shall pay to such
Holder, in cash, as liquidated damages and not as a penalty, $1,000 for each day
after such (5th) fifth (or seventh (7th) as the case may be), trading day until
such certificates are delivered. Nothing herein shall limit the Holder's right
to pursue actual damages for the Company's failure to deliver certificates
representing shares of Common Stock upon exercise within the period specified
herein and the Holder shall have the right to pursue all remedies available to
it at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief. The exercise of any such rights shall not
prohibit the Holder from seeking to enforce damages pursuant to any other
Section hereof or under applicable law.

         10.      Supplements and Amendments: Whole Agreement.  This Warrant
may be amended or supplemented only by an instrument in writing signed by the
parties hereto. This Warrant of even date herewith contain the full
understanding of the parties hereto with respect to the subject matter hereof
and thereof and there are no representations, warranties, agreements or
understandings other than expressly contained herein and therein.

         11.      Governing Law.  This Warrant shall be deemed to be a contract
made under the laws of the State of New York and for all purposes shall be
governed by and construed in accordance with the laws of such State. Each of the
parties consents to the exclusive jurisdiction of the federal courts whose State
of New York sitting in the City of New York in connection with any dispute
arising under this Agreement.

         12.      Counterparts.  This Warrant may be executed in any number of
counterparts and each of such counterparts shall for all purposes be deemed to
be an original, and all such counterparts shall together constitute but one and
the same instrument.

         13.      Descriptive Headings.  Descriptive headings of the several
Sections of this Warrant are inserted for convenience only and shall not control
or affect the meaning or construction of any of the provisions hereof.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       5
<PAGE>   6

         IN WITNESS WHEREOF, the parties hereto have executed this Warrant as
of the __ day of September, 2000.

                                             SATX, INC.

                                             By:
                                                --------------------------------

                                             -----------------------------------

                                             Its
                                                --------------------------------

Attest:
       -----------------------------

                                       6<PAGE>   1
                                                                    EXHIBIT 10.1

                         SECURITIES PURCHASE AGREEMENT

         THIS SECURITIES PURCHASE AGREEMENT, dated as of the date of acceptance
set forth below, is entered into by and between SATX, INC. a Nevada corporation,
with headquarters located at 4710 Eisenhower Blvd, Suite B-2, Tampa, Florida
33634 (the "Company"), and each entity named on a signature page hereto (each,
a "Buyer") (each agreement with a Buyer being deemed a separate and independent
agreement between the Company and such Buyer, except that each Buyer
acknowledges and consents to the rights granted to each other Buyer under such
agreement and the Transaction Agreements, as defined below, referred to
therein).

                                   WITNESSETH:

         WHEREAS, the Company and the Buyer are executing and delivering this
Agreement in accordance with and in reliance upon the exemption from securities
registration afforded, inter alia, by Rule 506 under Regulation D ("Regulation
D") as promulgated by the United States Securities and Exchange Commission (the
"SEC") under the Securities Act of 1933, as amended (the "1933 Act"), and/or
Section 4(2) of the 1933 Act; and

         WHEREAS, the Buyer wishes to purchase, upon the terms and subject to
the conditions of this Agreement, 8% Convertible Debentures of the Company
(the "Convertible Debentures") which will be convertible into shares of
Common Stock, $.001 par value per share, of the Company (the "Common Stock"),
upon the terms and subject to the conditions of such Convertible Debentures,
together with the Warrants (as defined below) exercisable for the purchase of
shares of Common Stock, and subject to acceptance of this Agreement by the
Company;

         NOW THEREFORE, in consideration of the premises and the mutual
covenants contained herein and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties agree as
follows:

         1.       AGREEMENT TO PURCHASE; PURCHASE PRICE.

                  a.       PURCHASE.

                           (i)      The undersigned hereby agrees to purchase
initially from the Company Convertible Debentures in the principal amount of
$250,000 (the "Initial Debentures") out of a total offering of not more than
$1,000,000 of such Convertible Debentures, and having the terms and conditions
and being in the form attached hereto as Annex 1.

                           (ii)     Subject to the terms and conditions of this
Agreement and the other

                                       1
<PAGE>   2

Transaction Agreements, the Buyer will purchase (x) the Initial Debentures on
the Initial Closing Date (as defined below) and (y) in three tranches (the
"Additional Tranche") the Additional Debentures of seven hundred fifty thousand
($750,000) Dollars on the Additional Closing Date (as those terms are defined
below).

                           (iii)    The purchase price to be paid by the Buyer
shall be equal to the face amount of the Initial Debentures and Additional
Debentures, as the case may be, being purchased on the relevant Closing Date
(as defined below) and shall be payable in United States Dollars.

                  b.       CERTAIN DEFINITIONS. As used herein, each of the
following terms has the meaning set forth below, unless the context otherwise
requires:

                           (i)      "Transaction Agreements" means the
Securities Purchase Agreement, the Registration Rights Agreement (as defined
below), the Debentures, the Warrants, and the Joint Escrow Instructions (as
defined below).

                           (ii)     "Debentures" means all or any portion of
the Initial Debentures and the Additional Debentures.

                           (iii)    "Securities" means the Debentures, the
Warrants and the Common Stock issuable upon conversion of the Debentures or the
exercise of the Warrants.

                           (iv)     "Purchase Price" means the purchase price
for the Initial Debentures or the Additional Debentures.

                           (v)      "Initial Closing Date" means the date of
the closing of the purchase and sale of the Initial Debentures, as provided
herein.

                           (vi)     "Additional Closing Date" means the date of
the closing of the purchase and sale of the relevant Additional Debentures, as
provided herein.

                           (vii)    "Closing Date" means the Initial Closing
Date or the relevant Additional Closing Date, as the case may be.

                           (viii)   "Filing Date" means the fling date of the
Registration Statement covering the Registrable Securities (as those terms are
defined in the Registration Rights Agreement defined below) for the Debentures
and Warrants issued on the Initial Closing Date and on the Additional Closing
Date

                           (ix)     "Effective Date" means the effective date
of the Registration Statement covering the Registrable Securities (as those
terms are defined in the Registration Rights Agreement

                                       2
<PAGE>   3

defined below) for the Debentures and Warrants issued on the Initial Closing
Date and on the Additional Closing Date, respectively.

                           (x)      "Market Price of the Common Stock" means
(x) the closing bid price of the Common Stock for the trading day immediately
before the relevant date indicated in the relevant provision hereof (unless a
different relevant period is specified in the relevant provision), as reported
by Bloomberg, LP. If Bloomberg LP is unavailable than as reported by Reuters
Group PLC.

                           (xi)     "Converted Shares" means the shares of
Common Stock issuable upon conversion of the Debentures.

                           (xii)    "Warrant Shares" means the shares of
Common Stock issuable upon exercise of the Warrants.

                           (xiii)   "Shares" means the shares of Common Stock
representing any or all of the Converted Shares and the Warrant Shares.

                           (xiv)    "Certificates" means the relevant
Debentures and the relevant Warrants, each duly executed on behalf of the
Company and issued in the name of the Buyer.

                           (xv)     "Person" means any living person or any
entity, such as, but not necessarily limited to, a corporation, partnership or
trust.

                           (xvi)    "Affiliate" means, with respect to a
specific Person referred to in the relevant provision, another Person who or
which controls or is controlled by or is under common control with such
specified Person.

                  c.       FORM OF PAYMENT; DELIVERY OF CERTIFICATES.

                           (i)      The Buyer shall pay the applicable Purchase
Price for the relevant Debentures by delivering immediately available good
funds in United States Dollars to the escrow agent (the "Escrow Agent")
identified in the Joint Escrow Instructions attached hereto as Annex II (the
"Joint Escrow Instructions") as set forth below.

                           (ii)     No later than the relevant Closing Date,
but in any event promptly following payment by the Buyer to the Escrow Agent of
the relevant Purchase Price, the Company shall deliver the relevant
Certificates to the Escrow Agent.

                           (iii)    By signing this Agreement, each of the
Buyer and the Company, subject to acceptance by the Escrow Agent, agrees to all
of the terms and conditions of, and becomes a party to, the Joint Escrow
Instructions, all of the provisions of which are incorporated herein by this
reference as if set forth in full.

                                       3
<PAGE>   4

                  d.       METHOD OF PAYMENT. Payment of the Purchase Price
shall be made by wire transfer of funds to:

             Bank of New York
             350 Fifth Avenue
             New York, New York 10001

             ABA# 021000018
             For credit to the account of Krieger & Prager, LLP.
             Account No.: [To be provided by Krieger & Prager LLP.]
             Re: SATX, Inc.

Not later than 5:00 p.m., New York time, on the date which is two (2) New York
Stock Exchange trading days after the Company shall have accepted this
Agreement and returned a signed counterpart of this Agreement to the Escrow
Agent by facsimile, the Buyer shall deposit with the Escrow Agent the Purchase
Price for the Debentures in currently available funds. Time is of the essence
with respect to such payment, and failure by the Buyer to make such payment
shall be a breach of this Agreement and shall allow the Company to cancel this
Agreement, and to pursue any other remedies available to it at law or in equity.

                  e.       ESCROW PROPERTY. The Purchase Price and the
Certificates delivered to the Escrow Agent as contemplated by Sections 1(c) and
(d) hereof are referred to as the "Escrow Property."

         2.       BUYER REPRESENTATIONS, WARRANTIES, ETC.; ACCESS TO
INFORMATION; INDEPENDENT INVESTIGATION.

         The Buyer represents and warrants to, and covenants and agrees with,
the Company as follows:

                  a.       The Buyer is purchasing the Debentures and the
Warrants and will be acquiring the Shares for its own account for investment
only and not with a view towards the public sale or distribution thereof and
not with a view to or for sale in connection with any distribution thereof,
except for resale pursuant to a Registration Statement.

                  b.       The Buyer is (i) an "accredited investor" as that
term is defined in Rule 501 of the General Rules and Regulations under the 1933
Act by reason of Rule 501(a)(3), (ii) experienced in making investments of the
kind described in this Agreement and the related documents, (iii) able, by
reason of the business and financial experience of its officers (if an entity)
and professional advisors (who are not affiliated with or compensated in any
way by the Company or any of its affiliates or selling agents), to protect its
own interests in connection with the

                                       4
<PAGE>   5

transactions described in this Agreement, and the related documents, and (iv)
able to afford the entire loss of its investment in the Securities.

                  c.       All subsequent offers and sales of the Debentures,
the Warrants and the Shares by the Buyer shall be made pursuant to registration
of the Shares under the 1933 Act or pursuant to an exemption from registration.

                  d.       The Buyer understands that the Debentures and the
Warrants are being offered and sold to it in reliance on specific exemptions
from the registration requirements of United States federal and state
securities laws and that the Company is relying upon the truth and accuracy of,
and the Buyer's compliance with, the representations, warranties, agreements,
acknowledgments and understandings of the Buyer set forth herein in order to
determine the availability of such exemptions and the eligibility of the Buyer
to acquire the Debentures and the Warrants.

                  e.       The Buyer and its advisors, if any, have been
furnished with all materials relating to the business, finances and operations
of the Company and materials relating to the offer and sale of the Debentures
and the offer of the Shares which have been requested by the Buyer, including
ANNEX V hereto. The Buyer and its advisors, if any, have been afforded the
opportunity to ask questions of the Company and have received complete and
satisfactory answers to any such inquiries. Without limiting the generality of
the foregoing, the Buyer has also had the opportunity to obtain and to review
the Company's (1) Quarterly Reports on Form 10-QSB for the fiscal quarters
ended March 31, 2000 and June 30, 2000, and (2) Form 8-K, dated May 23, 2000
(as originally filed and as amended, (the "Company's SEC Documents").

                  f.       The Buyer understands that its investment in the
Securities involves a high degree of risk.

                  g.       The Buyer understands that no United States federal
or state agency or any other government or governmental agency has passed on or
made any recommendation or endorsement of the Securities.

                  h.       This Agreement has been duly and validly authorized,
executed and delivered on behalf of the Buyer and is a valid and binding
agreement of the Buyer enforceable in accordance with its terms, subject as to
enforceability to general principles of equity and to bankruptcy, insolvency,
moratorium and other similar laws affecting the enforcement of creditors'
rights generally.

         3.       COMPANY REPRESENTATIONS, ETC. The Company represents and
warrants to the Buyer that, except as provided in ANNEX V hereto:

                                       5
<PAGE>   6

                  a.       CONCERNING THE DEBENTURES AND THE SHARES. There are
no preemptive rights of any stockholder of the Company, as such, to acquire the
Debentures, the Warrants or the Shares.

                  b.       REPORTING COMPANY STATUS. The Company is a
corporation duly organized, validly existing and in good standing under the
laws of the State of Nevada and has the requisite corporate power to own its
properties and to carry on its business as now being conducted. The Company is
duly qualified as a foreign corporation to do business and is in good standing
in each jurisdiction where the nature of the business conducted or property
owned by it makes such qualification necessary, other than those jurisdictions
in which the failure to so qualify would not have a material adverse effect on
the business, operations or condition (financial or otherwise) or results of
operation of the Company and its subsidiaries taken as a whole. The Common
Stock is listed and traded on The NASDAQ/OTC Bulletin Board. The Company has
received no notice, either oral or written, with respect to the loss of
eligibility of the Common Stock for such listing, and the Company has
maintained all requirements for the continuation of such listing.

                  c.       AUTHORIZED SHARES. The authorized capital stock of
the Company consists of 100,000,000 shares of Common Stock, $.001 par value per
share, of which approximately shares had been issued as of September 2000.
All of the issued and outstanding shares of Common Stock have been duly
authorized and validly issued and are fully paid and nonassessable. The Company
has sufficient authorized and unissued shares of Common Stock as may be
necessary to effect the issuance of the Shares. The Shares have been duly
authorized and, when issued upon conversion of, or as interest on, the
Debentures or upon exercise of the Warrants, each in accordance with its
respective terms, will be duly and validly issued, fully paid and
non-assessable and will not subject the holder thereof to personal liability by
reason of being such holder.

                  D.       SECURITIES PURCHASE AGREEMENT; REGISTRATION RIGHTS
AGREEMENT AND STOCK. This Agreement and the Registration Rights Agreement, the
form of which is attached hereto as ANNEX IV (the "Registration Rights
Agreement"), and the transactions contemplated thereby, have been duly and
validly authorized by the Company, this Agreement has been duly executed and
delivered by the Company and this Agreement is, and the Debentures, the
Warrants and the Registration Rights Agreement, when executed and delivered by
the Company, will be, valid and binding agreements of the Company enforceable
in accordance with their respective terms, subject as to enforceability to
general principles of equity and to bankruptcy, insolvency, moratorium, and
other similar laws affecting the enforcement of creditors' rights generally.

                  e.       NON-CONTRAVENTION. The execution and delivery of
this Agreement and the Registration Rights Agreement by the Company, the
issuance of the Securities, and the consummation by the Company of the other
transactions contemplated by this Agreement, the Registration Rights Agreement,
and the Debentures do not and will not conflict with or result in a breach by
the Company of any of the terms or provisions of, or constitute a default under
(i) the

                                       6
<PAGE>   7

articles of incorporation or by-laws of the Company, each as currently in
effect, (ii) any indenture, mortgage, deed of trust, or other material
agreement or instrument to which the Company is a party or by which it or any
of its properties or assets are bound, including any listing agreement for the
Common Stock except as herein set forth, or (iii) to its knowledge, any
existing applicable law, rule, or regulation of any applicable decree,
judgment, or order of any court, United States federal or state regulatory
body, administrative agency, or other governmental body having jurisdiction
over the Company or any of its properties or assets, except such conflict,
breach or default which would not have a material adverse effect on the
business, operations or condition (financial or otherwise) or results of
operations of the Company and its subsidiaries, taken as a whole, or on the
transactions contemplated herein.

                  f.       APPROVALS. No authorization, approval or consent of
any court, governmental body, regulatory agency, self-regulatory organization,
or stock exchange or market or the stockholders of the Company is required to
be obtained by the Company for the issuance and sale of the Securities to the
Buyer as contemplated by this Agreement, except such authorizations, approvals
and consents that have been obtained.

                  g.       SEC FILINGS. None of the Company's SEC Documents
contained, at the time they were filed, any untrue statement of a material fact
or omitted to state any material fact required to be stated therein or
necessary to make the statements made therein in light of the circumstances
under which they were made, not misleading.

                  h.       ABSENCE OF CERTAIN CHANGES. Since December 31,1999,
there has been no material adverse change and no material adverse development
in the business, properties, operations, condition (financial or otherwise), or
results of operations of the Company, except as disclosed in the Company's SEC
Documents. Since December 31,1999, except as provided in the Company's SEC
Documents, the Company has not (i) incurred or become subject to any material
liabilities (absolute or contingent) except liabilities incurred in the
ordinary course of business consistent with past practices; (ii) discharged or
satisfied any material lien or encumbrance or paid any material obligation or
liability (absolute or contingent), other than current liabilities paid in the
ordinary course of business consistent with past practices; (iii) declared or
made any payment or distribution of cash or other property to stockholders with
respect to its capital stock, or purchased or redeemed, or made any agreements
to purchase or redeem, any shares of its capital stock; (iv) sold, assigned or
transferred any other tangible assets, or canceled any debts or claims, except
in the ordinary course of business consistent with past practices; (v) suffered
any substantial operating losses or waived any rights of material value,
whether or not in the ordinary course of business, or suffered the loss of any
material amount of existing business; (vi) made any changes in employee
compensation, except in the ordinary course of business consistent with past
practices; or (vii) experienced any material problems with labor or management
in connection with the terms and conditions of their employment.

                                       7
<PAGE>   8

                  i.       FULL DISCLOSURE. There is no fact known to the
Company (other than general economic conditions known to the public generally
or as disclosed in the Company's SEC Documents) that has not been disclosed in
writing to the Buyer that (i) would reasonably be expected to have a material
adverse effect on the business or condition of the Company (financial or
otherwise) or results of operations of the Company and its subsidiaries, taken
as a whole, (ii) would reasonably be expected to materially and adversely
affect the ability of the Company to perform its obligations pursuant to this
Agreement or any of the agreements contemplated hereby (collectively, including
this Agreement, the "Transaction Agreements"), or (iii) would reasonably be
expected to materially and adversely affect the value of the rights granted to
the Buyer in the Transaction Agreements.

                  j.       ABSENCE OF LITIGATION. Except as set forth in the
Company's SEC Documents, there is no action, suit, proceeding, inquiry or
investigation before or by any court, public board or body pending or, to the
knowledge of the Company, threatened against or affecting the Company, wherein
an unfavorable decision, ruling or finding would have a material adverse
effect on the properties, business or financial condition, or results of
operation of the Company and its subsidiaries taken as a whole or the
transactions contemplated by any of the Transaction Agreements or which would
adversely affect the validity or enforceability of, or the authority or ability
of the Company to perform its obligations under, any of the Transaction
Agreements.

                  k.       ABSENCE OF EVENTS OF DEFAULT. Except as set forth in
Section 3(e) hereof, no Event of Default (or its equivalent term), as defined
in the respective agreement to which the Company is a party, and no event
which, with the giving of notice or the passage of time or both, would become
an Event of Default (or its equivalent term) (as so defined in such agreement),
has occurred and is continuing, which would have a material adverse effect on
the business, operations or the condition (financial or otherwise) or results
of operations of the Company and its subsidiaries, taken as a whole.

                  1.       PRIOR ISSUES. During the twelve (12) months
preceding the date hereof, the Company has not issued any convertible
securities or, except as provided in the Company's SEC Documents, any shares of
the Common Stock or Preferred Stock.

                  m.       NO UNDISCLOSED LIABILITIES OR EVENTS. There are no
proposals currently under consideration or currently anticipated to be under
consideration by the Board of Directors or the executive officers of the
Company which proposal would (x) change the certificate of incorporation or
other charter document or by-laws of the Company, each as currently in effect,
with or without shareholder approval, which change would reduce or otherwise
adversely affect the rights and powers of the shareholders of the Common Stock
or (y) materially or substantially change the business, assets or capital of
the Company, including its interests in subsidiaries.

                                       8
<PAGE>   9

                  n.       NO DEFAULT. The Company is not in default in the
performance or observance of any material obligation, agreement, covenant or
condition contained in any material indenture, mortgage, deed of trust or other
material instrument or agreement to which it is a party or by which it or its
property is bound.

                  o.       NO INTEGRATED OFFERING. Neither the Company nor any
of its affiliates nor any person acting on its or their behalf has, directly or
indirectly, at any time since March 1, 1998, made any offer or sales of any
security or solicited any offers to buy any security under circumstances that
would eliminate the availability of the exemption from registration under Rule
506 of Regulation D in connection with the offer and sale of the Securities as
contemplated hereby.

                  p.       DILUTION. The number of Shares issuable upon
conversion of the Debentures and the exercise of the Warrants may increase
substantially in certain circumstances, including, but not necessarily limited
to, the circumstance wherein the trading price of the Common Stock declines
prior to the conversion of the Debentures. The Company's executive officers and
directors have studied and fully understand the nature of the Securities being
sold hereby and recognize that they have a potential dilutive effect. The board
of directors of the Company has concluded, in its good faith business judgment,
that such issuance is in the best interests of the Company. The Company
specifically acknowledges that its obligation to issue the Shares upon
conversion of the Debentures and upon exercise of the Warrants is binding upon
the Company and enforceable regardless of the dilution such issuance may have
on the ownership interests of other shareholders of the Company.

                  q.       BROKERS, FINDERS. Except for payment of fees to
Kaftan Family Trust (the "Placement Agent"), payment of which is the sole
responsibility of the Company, the Company has taken no action which would give
rise to any claim by any person for brokerage commission, finder's fees or
similar payments by Buyer relating to this Agreement or the transactions
contemplated hereby. Buyer shall have no obligation with respect to such fees
or with respect to any claims made by or on behalf of other persons for fees of
a type contemplated in this Section 3(q) that may be due in connection with the
transactions contemplated hereby. The Company shall indemnify and hold harmless
each of Buyer, its employees, officers, directors, agents, and partners, and
their respective affiliates, from and against all claims, losses, damages,
costs (including the costs of preparation and attorney's fees) and expenses
suffered in respect of any such claimed or existing fees, as and when incurred.

         4.       CERTAIN COVENANTS AND ACKNOWLEDGMENTS.

                  a.       Transfer Restrictions. The Buyer acknowledges that
(1) the Debentures have not been and are not being registered under the
provisions of the 1933 Act and, except as provided in the Registration Rights
Agreement, the Shares have not been and are not being registered under the 1933
Act, and may not be transferred unless (A) subsequently registered thereunder
or (B) the

                                       9
<PAGE>   10

Buyer shall have delivered to the Company an opinion of counsel, reasonably
satisfactory in form, scope and substance to the Company, to the effect that
the Securities to be sold or transferred may be sold or transferred pursuant to
an exemption from such registration; (2) any sale of the Securities made in
reliance on Rule 144 promulgated under the 1933 Act may be made only in
accordance with the terms of said Rule and further, if said Rule is not
applicable, any resale of such Securities under circumstances in which the
seller, or the person through whom the sale is made, may be deemed to be an
underwriter, as that term is used in the 1933 Act, may require compliance with
some other exemption under the 1933 Act or the rules and regulations of the SEC
thereunder; and (3) neither the Company nor any other person is under any
obligation to register the Securities (other than pursuant to the Registration
Rights Agreement) under the 1933 Act or to comply with the terms and conditions
of any exemption thereunder.

                  b.       RESTRICTIVE LEGEND. The Buyer acknowledges and
agrees that the Debentures and the Warrants, and, until such time as the Common
Stock has been registered under the 1933 Act as contemplated by the
Registration Rights Agreement and sold in accordance with an effective
Registration Statement, certificates and other instruments representing any of
the Securities shall bear a restrictive legend in substantially the following
form (and a stop-transfer order may be placed against transfer of any such
Securities):

                  THESE SECURITIES (THE "SECURITIES") HAVE
                  NOT BEEN REGISTERED UNDER THE SECURITIES
                  ACT OF 1933, AS AMENDED (THE "SECURITIES
                  ACT"), OR THE SECURITIES LAWS OF ANY STATE
                  AND MAY NOT BE SOLD OR OFFERED FOR SALE IN
                  THE ABSENCE OF AN EFFECTIVE REGISTRATION
                  STATEMENT FOR THE SECURITIES OR AN OPINION
                  OF COUNSEL OR OTHER EVIDENCE ACCEPTABLE
                  TO THE CORPORATION THAT SUCH REGISTRATION
                  IS NOT REQUIRED.

                  c.       REGISTRATION RIGHTS AGREEMENT. The parties hereto
agree to enter into the Registration Rights Agreement on or before the Closing
Date.

                  d.       FILINGS. The Company undertakes and agrees to make
all necessary filings in connection with the sale of the Securities to the
Buyer under any United States laws and regulations applicable to the Company,
or by any domestic securities exchange or trading market, and to provide a copy
thereof to the Buyer promptly after such filing.

                  e.       REPORTING STATUS. So long as the Buyer beneficially
owns any of the Securities, the Company shall file all reports required to be
filed with the SEC pursuant to Section 13 or 15(d) of the 1934 Act, and the
Company shall not terminate its status as an issuer required to file reports
under the 1934 Act even if the 1934 Act or the rules and regulations thereunder
would permit such termination. The Company will take all reasonable action
under its control to obtain and

                                      10
<PAGE>   11

to continue the listing and trading of its Common Stock (including, without
limitation, all Registrable Securities) on The NASDAQ/OTC Bulletin Board
System and will comply in all material respects with the Company's reporting,
filing and other obligations under the by-laws or rules of the National
Association of Securities Dealers, Inc. ("NASD") or The NASDAQ/OTC Bulletin
Board System.

                  f.       USE OF PROCEEDS. The Company will use the proceeds
from the sale of the Debentures (excluding amounts paid by the Company for
legal fees, finders fees and escrow fees in connection with the sale of the
Debentures) for internal working capital, acquisition and joint venture
purposes, and, unless specifically consented to in advance in each instance by
the Buyer, the Company shall not, directly or indirectly, use such proceeds for
the repayment of any outstanding loan by the Company to any other party or the
redemption of any existing convertible securities.

                  g.       AVAILABLE SHARES. The Company shall have at all
times authorized and reserved for issuance, free from preemptive rights, shares
of Common Stock sufficient to yield two hundred percent (200%) of the number of
shares of Common Stock issuable (i) at conversion as may be required to satisfy
the conversion rights based on the Fixed Conversion Rate (as defined in the
Debenture) as in effect from time to time of the Buyer pursuant to the terms
and conditions of the Debentures which have been issued and not yet converted
or the maximum amount of Additional Debentures which may be issued on the
Additional Closing Date and (ii) upon exercise as may be required to satisfy
the exercise rights of the Buyer pursuant to the terms and conditions of the
Warrants which have been issued and not yet exercised or the maximum amount of
Warrants which would be issued on the Additional Closing Date (assuming the
maximum amount of Additional Debentures would be issued on such date).

                  h.       WARRANTS. (i) The Company agrees to issue to the
Buyer on each Closing Date transferable, divisible warrants with a cashless
exercise provision (the "Warrants") for the purchase of one hundred thousand
(100,000) shares of the Common Stock of the Company for each $250,000 of
Debentures purchased and shall bear an exercise price per share equal to (x)
120% of (y) Weighted Average Conversion Price (as defined below).

         "W.A.C.P." means (i) the suns of the Conversion Principal (as defined
below) for all conversions of the Debenture prior to such exercise, divided by
(ii) the aggregate principal of the Debenture converted prior to such exercise.

         "Conversion Principal" means, for each conversion, (x) the principal
amount of the Debenture converted by such conversion, multiplied by (y) the
Conversion Price applicable to that conversion.

                                      11
<PAGE>   12

         The Warrants will expire on the last day of the month in which the
fifth anniversary of the relevant Closing Date occurs and shall be in the form
annexed hereto as ANNEX VI, together with registration rights as provided in
the Registration Rights Agreement and piggy-back registration after the
expiration of the effectiveness of the Registration Statement contemplated by
the Registration Rights Agreement.

                  i.       FUTURE PURCHASES. (i) The Buyer hereby has the
option to purchase from the Company during the nine (9) months after the
Initial Closing Date up to $750,000 of Debentures ("Additional Debentures") in
three Additional Tranches of $250,000 each on and subject to the terms and
conditions provided in this Section 4(i).

                           (ii)     The date of the closing (the "Additional
Closing Date" or a "Closing Date") for the Additional Tranches, shall be not
later than the fifth (5) Trading Day after the Buyer's Exercise Notice.

                           (iii)    Except as specifically provided in this
Section 4(j), the purchase and sale of Additional Debentures effected on the
Additional Closing Dates shall be conducted as if it were the transactions
referred to in the Transaction Agreements (other than this Section 4(j)). By
way of illustration, and not in limitation, of the foregoing, each of the
Company and the Buyer shall be deemed to have made all of the representation,
warranties and covenants set forth in the Transaction Agreements as of the
Additional Closing Dates, and the terms of the Registration Rights Agreement
will apply to the Additional Debentures and the related Warrants. Specifically,
the Company acknowledges its obligation to register the Registrable Securities
applicable to the Additional Tranche independent of any other effective
registration applicable to Registrable Securities relating to prior Debentures
and related Warrants purchased on any prior Closing Date.

                           (iv)     Each Additional Debenture shall be in the
form annexed hereto as ANNEX 1.

                           (v)      Except to the extent specifically
contemplated by the provisions of this Section 4(i), the closing of the
Additional Tranche shall be conducted upon the same terms and conditions as
those applicable to the closing held on the Initial Closing Date.

                           (vi)     In the event the Company obtains a finance
commitment in an amount exceeding $1,500,000 from a bona fide unaffiliated
financing source at any time prior to the Buyer exercising the option to
purchase all of the Additional Debentures as set forth in this Paragraph i(i),
and such financing source objects to the granting of any unexercised portion of
the option, than the option of the Buyer to purchase the Additional Debentures
is canceled without the Company incurring any further liability towards the
Buyer as of the closing of such financing.

                                      12
<PAGE>   13

                  j.       REIMBURSEMENT. If (i) any Buyer, other than by
reason of its gross negligence or willful misconduct, becomes involved in any
capacity in any action, proceeding or investigation brought by any stockholder
of the Company, in connection with or as a result of the consummation of the
transactions contemplated by the Transaction Agreements, or if such Buyer is
impleaded in any such action, proceeding or investigation by any Person, or
(ii) any Buyer, other than by reason of its gross negligence or willful
misconduct or by reason of its trading of the Common Stock in a manner that is
illegal under the federal securities laws, becomes involved in any capacity in
any action, proceeding or investigation brought by the SEC against or involving
the Company or in connection with or as a result of the consummation, of the
transactions contemplated by the Transaction Agreements, or if such Buyer is
impleaded in any such action, proceeding or investigation by any Person, then
in any such case, the Company will reimburse such Buyer for its reasonable
legal and other expenses (including the cost of any investigation and
preparation) incurred in connection therewith, as such expenses are incurred.
The reimbursement obligations of the Company under this paragraph shall be in
addition to any liability which the Company may otherwise have, shall extend
upon the same terms and conditions to any Affiliates of the Buyers who are
actually named in such action, proceeding or investigation, and partners,
directors, agents, employees and controlling persons (if any), as the case may
be, of the Buyers and any such Affiliate, and shall be binding upon and inure
to the benefit of any successors, assigns, heirs and personal representatives
of the Company, the Buyers and any such Affiliate and any such Person. The
Company also agrees that neither any Buyer nor any such Affiliate, partners,
directors, agents, employees or controlling persons shall have any liability to
the Company or any person asserting claims on behalf of or in right of the
Company in connection with or as a result of the consummation of the
Transaction Agreements except to the extent that any losses, claims, damages,
liabilities or expenses incurred by the Company result from the gross
negligence, willful misconduct or material breach of such Buyer.

         5.       TRANSFER AGENT INSTRUCTIONS.

                  a.       Promptly following the delivery by the Buyer of the
Purchase Price for the Initial Debentures in accordance with Section 1(c)
hereof, the Company will irrevocably instruct its transfer agent to issue
Common Stock from time to time upon conversion of the Debentures in such
amounts as specified from time to time by the Company to the transfer agent,
bearing the restrictive legend specified in Section 4(b) of this Agreement
prior to registration of the Shares under the 1933 Act, registered in the name
of the Buyer or its nominee and in such denominations to be specified by the
Buyer in connection with each conversion of the Debentures. The Company
warrants that no instruction other than such instructions referred to in this
Section 5 and stop transfer instructions to give effect to Section 4(a) hereof
prior to registration and sale of the Shares under the 1933 Act will be given
by the Company to the transfer agent and that the Shares shall otherwise be
freely transferable on the books and records of the Company as and to the
extent provided in this Agreement, the Registration Rights Agreement, and
applicable law. Nothing in this Section shall

                                      13
<PAGE>   14

affect in any way the Buyer's obligations and agreement to comply with all
applicable securities laws upon resale of the Securities. If the Buyer provides
the Company and its counsel with an opinion of counsel reasonably satisfactory
to the Company that registration of a resale by the Buyer of any of the
Securities in accordance with clause (1)(B) of Section 4(a) of this Agreement
is not required under the 1933 Act, the Company shall (except as provided in
clause (2) of Section 4(a) of this Agreement) permit the transfer of the
Securities and, in the case of the Converted Shares or the Warrant Shares, as
the case may be, promptly instruct the Company's transfer agent to issue one or
more certificates for Common Stock without legend in such name and in such
denominations as specified by the Buyer.

                  b.       (i) The Company will permit the Buyer to exercise
its right to convert the Debentures or part thereof by telecopying or
delivering an executed and completed Notice of Conversion to the Company and
delivering, within five (5) business days thereafter, the original Debentures
being converted to the Company by express courier, with a copy to the Company's
transfer agent.

                           (ii)     The term "Conversion Date" means, with
respect to any conversion elected by the holder of the Debentures, the date
specified in the Notice of Conversion, provided the copy of the Notice of
Conversion is telecopied to or otherwise delivered to the Company in accordance
with the provisions hereof so that it is received by the Company on or before
such specified date.

                           (iii)    The Company will transmit the certificates
representing the Converted Shares (together, unless otherwise instructed by the
Buyer, with Debentures not being so converted) to the Buyer at the address
specified in the Notice of Conversion (which may be the Buyer's address for
notices as contemplated by Section 11 hereof or a different address) via
express courier by electronic transfer or otherwise, within five (5) business
days if the address for delivery is in the United States and within seven (7)
business days if the address for delivery is outside the United States (such
fifth business day or seventh business day, as the case may be, the "Delivery
Date") after the business day on which the Company has received both of the
Notice of Conversion (by facsimile or other delivery) and the original
Debentures being converted (and if the same are not delivered to the Company on
the same date, the date of delivery of the second of such items).

                  c.       The Company understands that a delay in the
issuance of the Shares of Common Stock beyond the Delivery Date could result in
economic loss to the Buyer. As compensation to the Buyer for such loss, the
Company agrees to pay late payments to the Buyer for late issuance of Shares
upon conversion in accordance with the following schedule (where "No. Business
Days Late" is defined as the number of business days beyond two (2) business
days from the Delivery Date):

                                      14
<PAGE>   15

                                             Late Payment For Each $10,000
                                           of Debenture Principal or Interest
         No. Business Days Late                 Amount Being Converted
         ----------------------            ----------------------------------
                  1                                       $100
                  2                                       $200
                  3                                       $300
                  4                                       $400
                  5                                       $500
                  6                                       $600
                  7                                       $700
                  8                                       $800
                  9                                       $900
                  10                                      $1,000
                  >10                                     $1,000+$200 for each
                                                          Business Day Late
                                                          beyond 10 days

The Company shall pay any payments incurred under this Section in immediately
available funds upon demand. Nothing herein shall limit the Buyer's right to
pursue actual damages for the Company's failure to issue and deliver the Common
Stock to the Buyer. Furthermore, in addition to any other remedies which may be
available to the Buyer, in the event that the Company fails for any reason to
effect delivery of such shares of Common Stock within two (2) business days
after the Delivery Date, the Buyer will be entitled to revoke the relevant
Notice of Conversion by delivering a notice to such effect to the Company
whereupon the Company and the Buyer shall each be restored to their respective
positions immediately prior to delivery of such Notice of Conversion.

                  d.       If, by the relevant Delivery Date, the Company fails
for any reason to deliver the Shares to be issued upon conversion of a
Debenture and after such Delivery Date, the holder of the Debentures being
converted (a "Converting Holder") purchases, in an open market transaction or
otherwise, shares of Common Stock (the "Covering Shares") in order to make
delivery in satisfaction of a sale of Common Stock by the Converting Holder
(the "Sold Shares"), which delivery such Converting Holder anticipated to make
using the Shares to be issued upon such conversion (a "Buy-In"), the Company
shall pay to the Converting Holder, in addition to all other amounts
contemplated in other provisions of the Transaction Agreements, and not in lieu
thereof, the Buy-In Adjustment Amount (as defined below). The "Buy-In
Adjustment Amount" is the amount equal to the excess, if any, of (x) the
Converting Holder's total purchase price (including brokerage commissions, if
any) for the Covering Shares over (y) the net proceeds (after brokerage
commissions, if any) received by the Converting Holder from the sale of the
Sold Shares. The Company shall pay the Buy-In Adjustment Amount to the Company
in immediately available funds immediately upon demand by the Converting
Holder. By way of illustration and riot in limitation of the foregoing, if the
Converting Holder purchases shares of Common Stock having a total purchase
price (including brokerage commissions) of $11,000 to cover a Buy-In with
respect to

                                      15
<PAGE>   16

shares of Common Stock it sold for net proceeds of $10,000, the Buy-In
Adjustment Amount which Company will be required to pay to the Converting
Holder will be $1,000.

                  e.       In lieu of delivering physical certificates
representing the Common Stock issuable upon conversion, provided the Company's
transfer agent is participating in the Depository Trust Company ("DTC") Fast
Automated Securities Transfer program, upon request of the Buyer and its
compliance with the provisions contained in this paragraph, so long as the
certificates therefor do not bear a legend and the Buyer thereof is not
obligated to return such certificate for the placement of a legend thereon, the
Company shall use its reasonable best efforts to cause its transfer agent to
electronically transmit the Common Stock issuable upon conversion to the Buyer
by crediting the account of Buyer's Prime Broker with DTC through its Deposit
Withdrawal Agent Commission system.

                  f.       The Company will authorize its transfer agent to
give information relating to the Company directly to the Buyer or the Buyer's
representatives upon the request of the Buyer or any such representative
relating to conversion and instructions hereunder. The Company will provide the
Buyer with a copy of the authorization so given to the transfer agent.

                  g.       The holder of any Debentures shall be entitled to
exercise its conversion privilege with respect to the Debentures
notwithstanding the commencement of any case under 11 U.S.C. ss.101 et seq.
(the "Bankruptcy Code"). In the event the Company is a debtor under the
Bankruptcy Code, the Company hereby waives, to the fullest extent permitted by
law, any rights to relief it may have under 11 U.S.C. ss.362 in respect of such
holder's conversion privilege. The Company hereby waives, to the fullest extent
permitted by law, any rights to relief it may have under 11 U.S.C. ss.362 in
respect of the conversion of the Debentures. The Company agrees, without cost
or expense to such holder, to take or to consent to any and all action
necessary to effectuate relief under 11 U.S.C. ss.362.

         6.       CLOSING DATES.

                  a.       The Initial Closing Date shall occur on the date
which is the first NYSE trading day after each of the conditions contemplated
by Sections 7 and 8 hereof shall have either been satisfied or been waived by
the party in whose favor such conditions run.

                  b.       The Additional Closing Date shall be the date
specified in the Tranche Notice, provided each of the conditions contemplated
by Section 4(i) and Sections 7 and 8 hereof shall have either been satisfied or
been waived by the party in whose favor such conditions run.

                  c.       Each closing of the purchase and issuance of
Debentures shall occur on the relevant Closing Date at the offices of the
Escrow Agent and shall take place no later than 3:00 P.M.,

                                      16
<PAGE>   17

New York time, on such day or such other time as is mutually agreed upon by the
Company and the Buyer.

                  d.       Notwithstanding anything to the contrary contained
herein, the Escrow Agent will be authorized to release the Escrow Funds to the
Company and to others and to release the other Escrow Property on the relevant
Closing Date upon satisfaction of the conditions set forth in Sections 7 and 8
hereof and as provided in the Joint Escrow Instructions.

         7.       CONDITIONS TO THE COMPANY'S OBLIGATION TO SELL.

         The Buyer understands that the Company's obligation to sell the
relevant Debentures to the Buyer pursuant to this Agreement on the relevant
Closing Date is conditioned upon:

                  a.       The execution and delivery of this Agreement by the
Buyer;

                  b.       Delivery by the Buyer to the Escrow Agent of good
funds as payment in full of an amount equal to the Purchase Price for the
relevant Debentures in accordance with this Agreement;

                  c.       The accuracy on such Closing Date of the
representations and warranties of the Buyer contained in this Agreement, each
as if made on such date, and the performance by the Buyer on or before such
date of all covenants and agreements of the Buyer required to be performed on
or before such date; and

                  d.       There shall not be in effect any law, rule or
regulation prohibiting or restricting the transactions contemplated hereby, or
requiring any consent or approval which shall not have been obtained.

         8.       CONDITIONS TO THE BUYER'S OBLIGATION TO PURCHASE.

         The Company understands that the Buyer's obligation to purchase the
Debentures on the relevant Closing Date is conditioned upon:

                  a.       The execution and delivery prior thereto of this
Agreement and the Registration Rights Agreement by the Company;

                  b.       Delivery by the Company to the Escrow Agent of the
relevant Certificates in accordance with this Agreement;

                  c.       The accuracy in all material respects on such
Closing Date of the representations and warranties of the Company contained in
this Agreement each as if made on such

                                      17
<PAGE>   18

date, and the performance in all material respects by the Company on or before
such date of all covenants and agreements of the Company required to be
performed on or before such date;

                  d.       On such Closing Date, the Registration Rights
Agreement shall be in full force and effect and the Company shall not be in
default thereunder;

                  e.       On such Closing Date, the Buyer shall have received
an opinion of counsel for the Company, dated such Closing Date, in form, scope
and substance reasonably satisfactory to the Buyer, substantially to the effect
set forth in ANNEX III attached hereto;

                  f.       There shall not be in effect any law, rule or
regulation prohibiting or restricting the transactions contemplated hereby, or
requiring any consent or approval which shall not have been obtained;

                  g.       The trading of the Common Stock is not suspended by
the SEC or the NASD and trading in securities generally on the New York Stock
Exchange or The NASDAQ/OTC Bulletin Board Market System is not suspended or
limited, nor shall minimum prices be established for securities traded on The
NASDAQ/OTC Bulletin Board Market System; and

                  h.       With respect to the Additional Closing Date,

                           (i)      the Tranche Notice shall have been duly
given;

                           (ii)     each of the conditions set forth in Section
4(i) shall either have been satisfied or been waived by the Buyer;

                           (iii)    the Company shall have timely issued all
shares issuable upon conversion of the Debentures prior to the date of the
Additional Closing Date;

                           (iv)     the Company shall have available and shall
reserve for issuance to Buyer shares of Common Stock equal to at least the sum
of (x) one hundred and fifty percent (150%) of the number of Shares which would
be issued on conversion of all unconverted previously issued Debentures and all
Additional Debentures to be issued on the relevant Additional Closing Date
(assuming that the Conversion Rate for all such Debentures were one hundred
fifteen percent (115%) of the Market Price of the Common Stock on the Initial
Closing Date) and (y) the number of shares issuable upon exercise of all
unexercised previously issued Warrants and all Warrants to be issued on the
relevant Additional Closing Date.

                                      18
<PAGE>   19

         9.       GOVERNING LAW: MISCELLANEOUS.

                  a.       This Agreement shall be governed by and interpreted
in accordance with the laws of the State of New York for contracts to be wholly
performed in such state and without giving effect to the principles thereof
regarding the conflict of laws. Each of the parties consents to the exclusive
jurisdiction of the federal courts whose districts encompass any part of the
City of New York or the state courts of the State of New York sitting in the
City of New York in connection with any dispute arising under this Agreement
and hereby waives, to the maximum extent permitted by law, any objection,
including any objection based on forum non conveniens, to the bringing of any
such proceeding in such jurisdictions. To the extent determined by such court,
the Company shall reimburse the Buyer for any reasonable legal fees and
disbursements incurred by the Buyer in enforcement of or protection of any of
its rights under any of the Transaction Agreements.

                  b.       Failure of any party to exercise any right or remedy
under this Agreement or otherwise, or delay by a party in exercising such right
or remedy, shall not operate as a waiver thereof.

                  c.       This Agreement shall inure to the benefit of and be
binding upon the successors and assigns of each of the parties hereto.

                  d.       All pronouns and any variations thereof refer to the
masculine, feminine or neuter, singular or plural, as the context may require.

                  e.       A facsimile transmission of this signed Agreement
shall be legal and binding on all parties hereto.

                  f.       This Agreement may be signed in one or more
counterparts, each of which shall be deemed an original.

                  g.       The headings of this Agreement are for convenience of
reference and shall not form part of, or affect the interpretation of, this
Agreement.

                  h.       If any provision of this Agreement shall be invalid
or unenforceable in any jurisdiction, such invalidity or unenforceability shall
not affect the validity or enforceability of the remainder of this Agreement or
the validity or enforceability of this Agreement in any other jurisdiction.

                  i.       This Agreement may be amended only by an instrument
in writing signed by the party to be charged with enforcement thereof.

                  j.       This Agreement supersedes all prior agreements and
understandings among

                                      19
<PAGE>   20

the parties hereto with respect to the subject matter hereof.

         10.      NOTICES. All notices, demands, requests, consents, approvals,
and other communications required or permitted hereunder shall be in writing
and, unless otherwise specified herein, shall be (a) personally served, (b)
deposited in the mail, registered or certified, return receipt requested,
postage prepaid, (c) delivered by reputable courier service which provides
evidence of delivery with charges prepaid, (d) transmitted by hand delivery, or
(e) by facsimile, addressed as set forth below or to such other address as such
party shall have specified most recently by written notice given in accordance
herewith. Any notice or other communication required or permitted to be given
hereunder shall be deemed effective (i) upon hand delivery or delivery at the
address or number designated below (if delivered on a business day during
normal business hours where such notice is to be received), or the first
business day following such delivery (if delivered other than on a business day
during normal business hours where such notice is to be received) (ii) on the
second business day following the date of mailing by express courier service or
on the fifth business day after deposited in the mail, in each case, fully
prepaid, addressed to such address, or upon actual receipt of such mailing,
whichever shall first occur or (iii) if by facsimile, upon confirmation of
receipt by the recipient or confirmation of transmission in another manner
provided in this Section 10. The addresses for such communications shall be:

             If to the Company:

                  SATX, Inc.
                  4710 Eisenhower Blvd.
                  Suite B-2
                  Tampa, Florida 33634
                  Attention: Merritt Jesson-President
                  Tel No.: (800)989-7289
                  Fax No.: (813)290-0616

             With a copy (which shall not constitute notice) to:

                  Frohling, Hudak & Pellegrino, LLC
                  425 Eagle Rock Avenue
                  Roseland, New Jersey 07068
                  Attention: John B. M. Frohling, Esq.
                  Tel No.: (973)-226-4600
                  Fax No.: (973)-226-0969

                                      20
<PAGE>   21

             If to Buyer:

             At the address set FORTH ON the signature page of this Agreement.

             With a copy ( which shall not constitute notice) to:

                  Krieger & Prager, LLP
                  39 Broadway, Suite 1440
                  New York, New York 10006
                  Attention: Samuel M. Krieger, Esq.
                  Tel No.: (212) 363-2900
                  Fax No.: (212) 363-2999

Either party hereto may from time to time change its address or facsimile
number for notices under this Section 10 by giving at least ten (10) days'
prior written notice of such changed address or facsimile number to the
other party hereto. Any notice required or permitted hereunder shall be given in
writing (unless otherwise specified herein).

         11.      SURVIVAL OF REPRESENTATIONS AND WARRANTIES. The Company's and
the Buyer's representations and warranties herein shall survive the execution
and delivery of this Agreement and the delivery of the Certificates and the
Warrants and the payment of the Purchase Price for the period one year
thereafter, and shall inure to the benefit of the Buyer and the Company and
their respective successors and assigns. The Company's covenants set forth in
Section 5 shall terminate upon the conversion of the Debentures and delivery of
Common Stock underlying such Debentures.

                  [BALANCE OF PAGE INTENTIONALLY LEFT BLANK.]

                                      21
<PAGE>   22

         IN WITNESS WHEREOF, this Agreement has been duly executed by the Buyer
by one of its officers thereunto duly authorized as of the date set forth below.

           AMOUNT AND PURCHASE PRICE OF INITIAL DEBENTURES: $250,000

                            SIGNATURES FOR ENTITIES

         IN WITNESS WHEREOF, the undersigned represents that the foregoing
statements are true and correct and that it has caused this Securities Purchase
Agreement to be duly executed on its behalf this ______ day of September, 2000.

c/o ALTON MANAGEMENT S.A.                    NASIMIA, Ltd
----------------------------------           ----------------------------------
                                             Printed Name of Subscriber
S/2 Junpers Building
Rosia Road
P.O. Box 795                                 By: /s/ D. Alton, Director
Gibralter                                       -------------------------------
----------------------------------              (Signature of authorized Person)
Address

Telecopier No. (011) 350-41555               ----------------------------------
----------------------------------           Printed Name and Title

MARSHALL ISLANDS
----------------------------------
Jurisdiction of Incorporation
or Organization

As of the date set forth below, the undersigned hereby accepts this Agreement
and represents that the foregoing statements are true and correct and that it
has caused this Securities Purchase Agreement to be duly executed on its
behalf.

SATX, INC.

By: /s/ Merritt Jesson
    ------------------------------
         Merritt Jesson

Title: President & CEO
       ---------------------------

Date:  September 11,2000
     -----------------------------

                                      22
<PAGE>   23
                  ANNEX I       FORM OF DEBENTURE

                  ANNEX II      JOINT ESCROW INSTRUCTIONS

                  ANNEX III     OPINION OF COUNSEL

                  ANNEX IV      REGISTRATION RIGHTS AGREEMENT

                  ANNEX V       COMPANY DISCLOSURE MATERIALS

                  ANNEX VI      FORM OF WARRANT

                                       23

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00024-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00024-of-00352.parquet"}]]